Menomune-A / C / Y / W-135 Drug Information [ Sanofi-Aventis ]

Table of content

Menomune-A / C / Y / W-135 category:

• Human
• Vaccines

Active ingredients:

• Meningococcal Polysaccharide Antigen Group A
• Meningococcal Polysaccharide Antigen Group C
• Meningococcal Polysaccharide Antigen Group W-135
• Meningococcal Polysaccharide Antigen Group Y

Menomune-A / C / Y / W-135 companies and manufacturers:

• Sanofi-Aventis

General Information

Menomune-A / C / Y / W-135 forms, composition and dosages:

• Injectable; Injection; Meningococcal Polysaccharide Antigen Group A 0.5 mg; Meningococcal Polysaccharide Antigen Group C 0.5 mg; Meningococcal Polysaccharide Antigen Group W-135 0.5 mg; Meningococcal Polysaccharide Antigen Group Y 0.5 mg
• Injectable; Injection; Meningococcal Polysaccharide Antigen Group A 2.5 mg; Meningococcal Polysaccharide Antigen Group C 2.5 mg; Meningococcal Polysaccharide Antigen Group W-135 2.5 mg; Meningococcal Polysaccharide Antigen Group Y 2.5 mg

Indications, usages and classification codes:

• J07AH04 - Meningococcus, Tetravalent Purified Polysaccharide Antigen

• Menomune-A / C / Y / W-135 similar